Cargando…

Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy?

OBJECTIVE: A 2007 study performed at Montefiore Medical Center (Bronx, NY) identified high prevalence of reduced bone density in an urban population of patients with epilepsy and suggested that bone mineralization screenings should be regularly performed for these patients. We conducted a long‐term...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Amitai S., Ferastraoaru, Victor, Tabatabaie, Vafa, Gitlevich, Tatyana R., Spiegel, Rebecca, Haut, Sheryl R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278536/
https://www.ncbi.nlm.nih.gov/pubmed/32524049
http://dx.doi.org/10.1002/epi4.12392
_version_ 1783543354430062592
author Miller, Amitai S.
Ferastraoaru, Victor
Tabatabaie, Vafa
Gitlevich, Tatyana R.
Spiegel, Rebecca
Haut, Sheryl R.
author_facet Miller, Amitai S.
Ferastraoaru, Victor
Tabatabaie, Vafa
Gitlevich, Tatyana R.
Spiegel, Rebecca
Haut, Sheryl R.
author_sort Miller, Amitai S.
collection PubMed
description OBJECTIVE: A 2007 study performed at Montefiore Medical Center (Bronx, NY) identified high prevalence of reduced bone density in an urban population of patients with epilepsy and suggested that bone mineralization screenings should be regularly performed for these patients. We conducted a long‐term follow‐up study to determine whether bone mineral density (BMD) loss, osteoporosis, and fractures have been successfully treated or prevented. METHODS: In the current study, patients from the 2007 study who had two dual‐energy absorptiometry (DXA) scans performed at least 5 years apart were analyzed. The World Health Organization (WHO) criteria to diagnose patients with osteopenia or osteoporosis were used, and each patient's probability of developing fractures was calculated with the Fracture Risk Assessment Tool (FRAX). RESULTS: The median time between the first and second DXA scans for the 81 patients analyzed was 9.4 years (range 5‐14.7). The median age at the first DXA scan was 41 years (range 22‐77). Based on WHO criteria, 79.0% of patients did not have worsening of bone density, while 21.0% had new osteopenia or osteoporosis; many patients were prescribed treatment for bone loss. Older age, increased duration of anti‐epileptic drug (AED) usage, and low body mass index (BMI) were risk factors for abnormal BMDs. Based on the first DXA scan, the FRAX calculator estimated that none of the patients in this study had a 10‐year risk of more than 20% for developing major osteoporotic fracture (hip, spine, wrist, or humeral fracture). However, in this population, 11 patients (13.6%) sustained a major osteoporotic fracture after their first DXA scan. SIGNIFICANCE: Despite being routinely screened and frequently treated for bone mineral density loss and fracture prevention, many patients with epilepsy suffered new major osteoporotic fractures. This observation is especially important as persons with epilepsy are at high risk for falls and traumas.
format Online
Article
Text
id pubmed-7278536
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72785362020-06-09 Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy? Miller, Amitai S. Ferastraoaru, Victor Tabatabaie, Vafa Gitlevich, Tatyana R. Spiegel, Rebecca Haut, Sheryl R. Epilepsia Open Full‐length Original Research OBJECTIVE: A 2007 study performed at Montefiore Medical Center (Bronx, NY) identified high prevalence of reduced bone density in an urban population of patients with epilepsy and suggested that bone mineralization screenings should be regularly performed for these patients. We conducted a long‐term follow‐up study to determine whether bone mineral density (BMD) loss, osteoporosis, and fractures have been successfully treated or prevented. METHODS: In the current study, patients from the 2007 study who had two dual‐energy absorptiometry (DXA) scans performed at least 5 years apart were analyzed. The World Health Organization (WHO) criteria to diagnose patients with osteopenia or osteoporosis were used, and each patient's probability of developing fractures was calculated with the Fracture Risk Assessment Tool (FRAX). RESULTS: The median time between the first and second DXA scans for the 81 patients analyzed was 9.4 years (range 5‐14.7). The median age at the first DXA scan was 41 years (range 22‐77). Based on WHO criteria, 79.0% of patients did not have worsening of bone density, while 21.0% had new osteopenia or osteoporosis; many patients were prescribed treatment for bone loss. Older age, increased duration of anti‐epileptic drug (AED) usage, and low body mass index (BMI) were risk factors for abnormal BMDs. Based on the first DXA scan, the FRAX calculator estimated that none of the patients in this study had a 10‐year risk of more than 20% for developing major osteoporotic fracture (hip, spine, wrist, or humeral fracture). However, in this population, 11 patients (13.6%) sustained a major osteoporotic fracture after their first DXA scan. SIGNIFICANCE: Despite being routinely screened and frequently treated for bone mineral density loss and fracture prevention, many patients with epilepsy suffered new major osteoporotic fractures. This observation is especially important as persons with epilepsy are at high risk for falls and traumas. John Wiley and Sons Inc. 2020-04-14 /pmc/articles/PMC7278536/ /pubmed/32524049 http://dx.doi.org/10.1002/epi4.12392 Text en © 2020 The Authors. Epilepsia Open published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Full‐length Original Research
Miller, Amitai S.
Ferastraoaru, Victor
Tabatabaie, Vafa
Gitlevich, Tatyana R.
Spiegel, Rebecca
Haut, Sheryl R.
Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy?
title Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy?
title_full Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy?
title_fullStr Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy?
title_full_unstemmed Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy?
title_short Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy?
title_sort are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy?
topic Full‐length Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278536/
https://www.ncbi.nlm.nih.gov/pubmed/32524049
http://dx.doi.org/10.1002/epi4.12392
work_keys_str_mv AT milleramitais arewerespondingeffectivelytobonemineraldensitylossandfracturerisksinpeoplewithepilepsy
AT ferastraoaruvictor arewerespondingeffectivelytobonemineraldensitylossandfracturerisksinpeoplewithepilepsy
AT tabatabaievafa arewerespondingeffectivelytobonemineraldensitylossandfracturerisksinpeoplewithepilepsy
AT gitlevichtatyanar arewerespondingeffectivelytobonemineraldensitylossandfracturerisksinpeoplewithepilepsy
AT spiegelrebecca arewerespondingeffectivelytobonemineraldensitylossandfracturerisksinpeoplewithepilepsy
AT hautsherylr arewerespondingeffectivelytobonemineraldensitylossandfracturerisksinpeoplewithepilepsy